Results 1 to 10 of about 16,409 (241)

Bioequivalence study of fluticasone propionate nebuliser suspensions in healthy Chinese subjects [PDF]

Frontiers in Pharmacology
BackgroundFluticasone propionate is a synthetic trifluoro-substituted glucocorticoid, a highly selective glucocorticoid receptor agonist. Fluticasone propionate nebuliser suspensions is an inhaled corticosteroid with the low systemic bioavailability ...
Feng Cheng, Tao Shen, Fucheng Zhang, Chenghao Lei, Ye Zhu, GuoJun Luo, Dawei Xiao   +6 more
doaj   +4 more sources

The effect of treatment with fexofenadine and fluticasone propionate on the gene expression levels of Th9 transcription factors in patients with allergic rhinitis [PDF]

Heliyon, 2021
T helper-9 (Th9) is a new T cell subset involved in allergic rhinitis (AR) pathogenesis. Fexofenadine and fluticasone propionate are the first effective line of AR treatment.
Ali asghar Askari, Parisa Feizollahi, Alireza Rezaiemanesh, Farhad Salari, Ali Gorgin Karaji   +4 more
doaj   +2 more sources

The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy [PDF]

BMC Nephrology, 2023
Background Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy worldwide, and lacks the effective treatment. The study was aimed to investigate the clinical efficacy of fluticasone propionate aerosol combined with angiotensin ...
Liping Sun, Xinyi Zi, Zhen Wang, Xinzhou Zhang   +3 more
doaj   +2 more sources

Effect of acupuncture therapy combined with fluticasone propionate in the treatment of persistent allergic rhinitis: study protocol for a randomized controlled trial [PDF]

Trials, 2022
Background Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated inflammatory response. Persistent allergic rhinitis (PAR) is a subtype of AR, but the treatment of PAR is still a problem.
Qi Fan, Yixuan Feng, Yan Hou, Feihu Wu, Wei Zhang, Wenbin Nie, Bin Li, Zhongyu Zhou, Wenbin Fu, Lei Shi, Zhongren Sun, Hong Zhao   +11 more
doaj   +2 more sources

Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial [PDF]

Therapeutic Advances in Respiratory Disease, 2018
Background: The efficacy and safety of fluticasone propionate/formoterol fumarate pressurized metered-dose inhaler (pMDI) (fluticasone/formoterol; Flutiform ® ; 100/10 µg b.i.d.) was compared with fluticasone propionate (Flixotide ® Evohaler ® pMDI; 100 ...
Anna Płoszczuk, Miroslava Bosheva, Kay Spooner, Tammy McIver, Sanjeeva Dissanayake   +4 more
doaj   +2 more sources

Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study [PDF]

The Egyptian Journal of Otolaryngology, 2021
Background Allergic rhinitis (AR) or Hay fever is a chronic inflammation of the nasal mucosa induced by IgE-mediated hypersensitivity due to exposure of various allergens. AR occurs as a response against these inhaled allergens that cause inflammation of
P. Kiruba Shankari, Swathi Suresh, Rukaiah Fatma Begum   +2 more
doaj   +2 more sources

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers. [PDF]

J Asthma Allergy, 2023
Qi W, Liu Y, Xue W, Li K, Gorski JC, Liu M, Yan T, Nguyen DT, Ramalingam RK.   +8 more
europepmc   +3 more sources

Fluticasone Propionate, 100 µg bid, Using a Non-CFC Propellant, HFA 134a, in Asthmatic Children [PDF]

Canadian Respiratory Journal, 2003
BACKGROUND: Secondary to phasing out chlorofluorocarbons (CFCs), the fluticasone propionate (FP) pressurized metered-dose inhaler has been formulated in a nonozone-depleting propellant, hydrofluoralkane (HFA) 134a.
Brian Lyttle, John Gillies, Maarja Panov, Andrzej Emeryk, Claire Wixon   +4 more
doaj   +2 more sources

Comparative efficacy of inhaled corticosteroids and leukotriene modifiers depending on ASP299GLY-TLR-4 polymorphism in patients with bronchial asthma in the population of AR Crimea. [PDF]

Medičnì Perspektivi, 2015
The study included 39 patients with bronchial asthma. All patients at baseline were stratified into two groups with the genotype AA and AG of polymorphism Asp299Gly TLR-4.
Yu. A. Bisyuk, A. I. Kurchenko, A. I. Dubovyi, V. E. Kondratiuk   +3 more
doaj   +2 more sources

Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients [PDF]

Journal of Clinical and Diagnostic Research, 2013
Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of
Bhanu Prakash Kolasani, Venu Madhavi Lanke, Sudheer Diyya   +2 more
doaj   +1 more source